http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2692095-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a615b6db0acb71ee30f71f157888ba2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9b0dc896b0c130d0b7227130b7c036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c12c6815af885117b3514cdb7765cae2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_155c93e6036d00fa591342fd4cfbd95f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3eb632593bab69d54ae3caf8004bea3d |
| publicationDate | 2018-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2692095-T3 |
| titleOfInvention | High-dose imatinib tablets |
| abstract | Oral immediate release pharmaceutical composition consisting of imatinib mesylate in an amount equivalent to 600 mg of imatinib in free base form and at least one pharmaceutically acceptable excipient, where the composition is in the form of a film-coated tablet that comprises 95% to 99% by weight of the mesylate salt of imatinib based on the total weight of the film-coated tablet in which the pharmaceutically acceptable excipients comprised in the core of the tablet are selected from the group consisting of diluents, glidants, lubricants , and their combinations, where: The diluents are selected from the group consisting of lactose, calcium carbonate, calcium sulfate, sugar, dextrates, dextrin, dextrose, dibasic calcium phosphate, kaolin, magnesium carbonate, magnesium oxide, maltodextrin , mannitol, polymethacrylates, potassium chloride, sodium chloride, sorbitol, talc and their combinations; glidants are selected from the group consisting of magnesium trisilicate, talc, and combinations thereof; and lubricants are selected from the group consisting of magnesium stearate, calcium stearate, glyceryl monostearate, glyceryl palmitostearate, hydrogenated castor oil, hydrogenated vegetable oil, mineral oil, polyethylene glycol, sodium benzoate, sodium lauryl sulfate, sodium stearyl fumarate, stearic acid, talc, zinc stearate, and combinations thereof. |
| priorityDate | 2013-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.